Reduced renal function is associated with progression to AIDS but not with overall mortality in HIV-infected kenyan adults not initially requiring combination antiretroviral therapy

Journal of the International AIDS Society

Volumn 14, Issue 1, 2011, Pages

  Gupta, Samir K ^a   Ong'Or, Willis Owino ^b   Shen, Changyu ^c   Musick, Beverly ^c   Goldman, Mitchell ^a   Wools Kaloustian, Kara ^a  

^a INDIANA UNIVERSITY   (United States)

^b MOI UNIVERSITY   (Kenya)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HEMOGLOBIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CREATININE CLEARANCE; DEATH; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; KENYA; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RISK FACTOR; WORLD HEALTH ORGANIZATION; DRUG COMBINATION; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; KIDNEY FUNCTION TEST; MORTALITY; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HIV INFECTIONS; HUMANS; KENYA; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; RETROSPECTIVE STUDIES;

EID: 79958115545     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.1186/1758-2652-14-31     Document Type: Article

References (27)

1. WHO, UNAIDS, 09 AIDS Epidemic Update UNAIDS WHO. Geneva
2. WHO, Antiretroviral treatment for adults and adolescents: Recommendations for a public health approach. 2006 revision Geneva http://www.who.int/hiv/pub/ guidelines/artadultguidelines.pdf
3. WHO, Rapid Advice: Antiretroviral Therapy for HIV Infection in Adults and Adolescents http://www.who.int/hiv/pub/arv/rapid-advice-art.pdf
4. Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. LI Gardner SD Holmberg JM Williamson LA Szczech CC Carpenter AM Rompalo P Schuman RS Klein Group HIVERS, Journal of Acquired Immune Deficiency Syndromes 2003 32 203 209 10.1097/00126334-200302010-00013 12571531 (Pubitemid 36222723)
5. Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. LA Szczech DR Hoover JG Feldman MH Cohen SJ Gange L Gooze NR Rubin MA Young X Cai Q Shi W Gao K Anastos, Clin Infect Dis 2004 39 1199 1206 10.1086/424013 15486845 (Pubitemid 40169320)
6. Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia. LB Mulenga G Kruse S Lakhi RA Cantrell SE Reid I Zulu EM Stringer Z Krishnasami A Mwinga MS Saag JS Stringer BH Chi, AIDS 2008 22 1821 1827 10.1097/QAD.0b013e328307a051 18753939
7. Responding to the HIV pandemic: the power of an academic medical partnership. RM Einterz S Kimaiyo HN Mengech BO Khwa-Otsyula F Esamai F Quigley JJ Mamlin, Acad Med 2007 82 812 818 10.1097/ACM.0b013e3180cc29f1 17762264 (Pubitemid 47356397)
8. Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya. K Wools-Kaloustian S Kimaiyo L Diero A Siika J Sidle CT Yiannoutsos B Musick R Einterz KH Fife WM Tierney, AIDS 2006 20 41 48 10.1097/01.aids.0000196177.65551.ea 16327318 (Pubitemid 41818113)
9. Scaling up antiretroviral therapy in resource-limited settings: Treatment guidelines for a public health approach. WHO, World Health Organization, Geneva 2004 http://www.who.int/hiv/pub/prev-care/en/arvrevision2003en.pdf
10. An electronic medical record system for ambulatory care of HIV-infected patients in Kenya. AM Siika JK Rotich CJ Simiyu EM Kigotho FE Smith JE Sidle K Wools-Kaloustian SN Kimaiyo WM Nyandiko TJ Hannan WM Tierney, Int J Med Inform 2005 74 345 355 10.1016/j.ijmedinf.2005.03.002 15893257 (Pubitemid 40694197)
11. Prediction of creatinine clearance from serum creatinine. DW Cockcroft MH Gault, Nephron 1976 16 31 41 10.1159/000180580 1244564
12. A simplified equation to predict glomerular filtration rate from serum creatinine (Abstract A0828). AS Levey T Green JW Kusek GJ Beck MS Group, J Am Soc Nephrol 2000 11
13. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. AS Levey J Coresh E Balk AT Kausz A Levin MW Steffes RJ Hogg RD Perrone J Lau G Eknoyan, Ann Intern Med 2003 139 137 147 12859163
14. Estimating glomerular filtration rate in HIV-infected adults in Africa: comparison of Cockcroft-Gault and Modification of Diet in Renal Disease formulae. W Stohr AS Walker P Munderi S Tugume CF Gilks JH Darbyshire J Hakim, Antiviral Therapy 2008 13 761 770 18839777
15. Checking the Cox model with cumulative sums of martingale-based residuals. DY Lin LJ Wei Z Ying, Biometrika 1993 80 557 572 10.1093/biomet/80.3. 557
16. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. S Rosen MP Fox CJ Gill, PLoS Medicine/Public Library of Science 2007 4 16
17. The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women. MM Estrella RS Parekh A Abraham BC Astor LA Szczech K Anastos JA Dehovitz DJ Merenstein CL Pearce PC Tien MH Cohen SJ Gange, J Acquir Immune Defic Syndr 2010 55 217 220 10.1097/QAI. 0b013e3181e674f4 20581688
18. Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach. EH Geng DR Bangsberg N Musinguzi N Emenyonu MB Bwana CT Yiannoutsos DV Glidden SG Deeks JN Martin, Journal of Acquired Immune Deficiency Syndromes 2010 53 405 411 10.1097/QAI.0b013e3181b843f0 19745753
19. Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya. CT Yiannoutsos MW An CE Frangakis BS Musick P Braitstein K Wools-Kaloustian D Ochieng JN Martin MC Bacon V Ochieng S Kimaiyo, PLoS ONE 2008 3 12 3843 10.1371/journal.pone.0003843 19048109
20. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. JW Mellors A Munoz JV Giorgi JB Margolick CJ Tassoni P Gupta LA Kingsley JA Todd AJ Saah R Detels JP Phair CR Rinaldo, Ann Intern Med 1997 126 946 954 9182471 (Pubitemid 27255797)
21. C-reactive protein is a marker for human immunodeficiency virus disease progression. B Lau AR Sharrett LA Kingsley W Post FJ Palella B Visscher SJ Gange, Arch Intern Med 2006 166 64 70 10.1001/archinte.166.1.64 16401812 (Pubitemid 43063843)
22. Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease. RC Kalayjian N Franceschini SK Gupta LA Szczech E Mupere RJ Bosch M Smurzynski JM Albert, AIDS 2008 22 481 487 10.1097/QAD.0b013e3282f4706d 18301060 (Pubitemid 351317289)
23. Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity. F Stam C van Guldener CG Schalkwijk PM ter Wee AJ Donker CD Stehouwer, Nephrology Dialysis Transplantation 2003 18 892 898 10.1093/ndt/gfg080 (Pubitemid 36592529)
24. Prognostic value of cross-sectional anthropometric indices on short-term risk of mortality in human immunodeficiency virus-infected adults in Abidjan, Cote d'Ivoire. K Castetbon X Anglaret S Toure G Chene T Ouassa A Attia T N'Dri-Yoman D Malvy R Salamon F Dabis CCS Group, American Journal of Epidemiology 2001 154 75 84 10.1093/aje/154.1.75 11427407 (Pubitemid 32565689)
25. Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis. Cross Continents Collaboration for Kids A C Writing, AIDS 2008 22 97 105 18090397
26. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. J Coresh BC Astor G McQuillan J Kusek T Greene F Van Lente AS Levey, Am J Kidney Dis 2002 39 920 929 10.1053/ajkd.2002.32765 11979335 (Pubitemid 34454210)
27. HIV-1 disease progression and AIDS-defining disorders in rural Uganda. D Morgan GH Maude SS Malamba MJ Okongo HU Wagner DW Mulder JA Whitworth, Lancet 1997 350 245 250 10.1016/S0140-6736(97)01474-8 9242801 (Pubitemid 27312294)